Prognostic value of pretreatment procalcitonin and neutrophil-lymphocyte ratio in extensive-stage small-cell lung cancer
CONCLUSION: Pretreatment PCT is an independent factor associated with PFS in extensive-stage SCLC patients treated with first-line chemotherapy, but pretreatment NLR reflects no significant prognostic value in our study.PMID:38536706 | PMC:PMC10978019 | DOI:10.1080/15384047.2024.2331273
Source: Cancer Biology and Therapy - Category: Cancer & Oncology Authors: Dongfang Chen Jianlin Xu Yizhuo Zhao Baohui Han Runbo Zhong Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Small Cell Lung Cancer | Study